Montine TJ - Search Results

1

Formation of highly reactive A-ring and J-ring isoprostane-like compounds (A4/J4-neuroprostanes) in vivo from docosahexaenoic acid.

Fam SS, Murphey LJ, Terry ES, Zackert WE, Chen Y, Gao L, Pandalai S, Milne GL, Roberts LJ, Porter NA, Montine TJ, Morrow JD. Fam SS, et al. Among authors: montine tj. J Biol Chem. 2002 Sep 27;277(39):36076-84. doi: 10.1074/jbc.M205638200. Epub 2002 Jul 19. J Biol Chem. 2002. PMID: 12133837 Free article.

2

Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid.

Roberts LJ 2nd, Montine TJ, Markesbery WR, Tapper AR, Hardy P, Chemtob S, Dettbarn WD, Morrow JD. Roberts LJ 2nd, et al. Among authors: montine tj. J Biol Chem. 1998 May 29;273(22):13605-12. doi: 10.1074/jbc.273.22.13605. J Biol Chem. 1998. PMID: 9593698 Free article.

3

Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease.

Montine TJ, Markesbery WR, Morrow JD, Roberts LJ 2nd. Montine TJ, et al. Ann Neurol. 1998 Sep;44(3):410-3. doi: 10.1002/ana.410440322. Ann Neurol. 1998. PMID: 9749613

4

Increased CSF F2-isoprostane concentration in probable AD.

Montine TJ, Beal MF, Cudkowicz ME, O'Donnell H, Margolin RA, McFarland L, Bachrach AF, Zackert WE, Roberts LJ, Morrow JD. Montine TJ, et al. Neurology. 1999 Feb;52(3):562-5. doi: 10.1212/wnl.52.3.562. Neurology. 1999. PMID: 10025788

5

Cerebrospinal fluid F2-isoprostanes are elevated in Huntington's disease.

Montine TJ, Beal MF, Robertson D, Cudkowicz ME, Biaggioni I, O'Donnell H, Zackert WE, Roberts LJ, Morrow JD. Montine TJ, et al. Neurology. 1999 Mar 23;52(5):1104-5. doi: 10.1212/wnl.52.5.1104. Neurology. 1999. PMID: 10102447 No abstract available.

6

Increased cerebral cortical lipid peroxidation and abnormal phospholipids in aged homozygous apoE-deficient C57BL/6J mice.

Montine TJ, Montine KS, Olson SJ, Graham DG, Roberts LJ 2nd, Morrow JD, Linton MF, Fazio S, Swift LL. Montine TJ, et al. Among authors: montine ks. Exp Neurol. 1999 Jul;158(1):234-41. doi: 10.1006/exnr.1999.7067. Exp Neurol. 1999. PMID: 10448437

7

The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients.

Montine TJ, Markesbery WR, Zackert W, Sanchez SC, Roberts LJ 2nd, Morrow JD. Montine TJ, et al. Am J Pathol. 1999 Sep;155(3):863-8. doi: 10.1016/S0002-9440(10)65185-1. Am J Pathol. 1999. PMID: 10487843 Free PMC article.

8

Elevated CSF prostaglandin E2 levels in patients with probable AD.

Montine TJ, Sidell KR, Crews BC, Markesbery WR, Marnett LJ, Roberts LJ 2nd, Morrow JD. Montine TJ, et al. Neurology. 1999 Oct 22;53(7):1495-8. doi: 10.1212/wnl.53.7.1495. Neurology. 1999. PMID: 10534257

9

Divergence of brain prostaglandin H synthase activity and oxidative damage in mice with encephalitis.

Valyi-Nagy T, Sidell KR, Marnett LJ, Roberts LJ 2nd, Dermody TS, Morrow JD, Montine TJ. Valyi-Nagy T, et al. Among authors: montine tj. J Neuropathol Exp Neurol. 1999 Dec;58(12):1269-75. doi: 10.1097/00005072-199912000-00008. J Neuropathol Exp Neurol. 1999. PMID: 10604752

10

Formation of novel isoprostane-like compounds from docosahexaenoic acid.

Morrow JD, Tapper AR, Zackert WE, Yang J, Sanchez SC, Montine TJ, Roberts LJ. Morrow JD, et al. Among authors: montine tj. Adv Exp Med Biol. 1999;469:343-7. doi: 10.1007/978-1-4615-4793-8_50. Adv Exp Med Biol. 1999. PMID: 10667351 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

552 results

Search Page

Filters